Selvita heads towards new development phase. Corporate and leadership changes, along with the purchase of a plot of land for further organic growth, as a starting point for new development strategy

Krakow, POLAND, Feb. 1, 2022 /PRNewswire/ — Selvita (WSE: SLV) – one of the largest preclinical contract research organizations in Europe, announced today changes to its leadership and organizational structure, aiming to support the Company’s further growth and strengthen its position on…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.